Insider · CIK 0001491874
Parker Geoffrey M.
Reports to the SEC for 9 companies · ALLEGAN, MI
Transactions
50
Companies
9
Filings
12
CIK
0001491874
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-09-11 | PRGOPERRIGO Co plcM Exercise/Conversion | +$17.3K |
| 2026-09-11 | PRGOPERRIGO Co plcF Tax Payment | −$8,291.62 |
| 2026-09-11 | PRGOPERRIGO Co plc · Restricted Stock UnitsM Exercise/Conversion | — |
| 2026-06-12 | PRGOPERRIGO Co plcM Exercise/Conversion | +$10.7K |
| 2026-06-12 | PRGOPERRIGO Co plcF Tax Payment | −$5,154.31 |
| 2026-06-12 | PRGOPERRIGO Co plc · Restricted Stock UnitsA Award | — |
| 2026-06-12 | PRGOPERRIGO Co plc · Restricted Stock UnitsM Exercise/Conversion | — |
| 2026-03-13 | PRGOPERRIGO Co plc · Restricted Stock UnitsA Award | — |
| 2026-02-02 | ALLOAllogene Therapeutics, Inc.S Sale | −$42.2K |
| 2026-02-02 | ALLOAllogene Therapeutics, Inc. · Stock Option (Right to buy)A Award | — |
| 2026-02-02 | ALLOAllogene Therapeutics, Inc. · Restricted Stock UnitA Award | — |
| 2025-12-12 | PRGOPERRIGO Co plc · Restricted Stock UnitsA Award | — |
| 2025-11-12 | PRGOPERRIGO Co plcP Purchase | +$106K |
| 2025-10-21 | ALLOAllogene Therapeutics, Inc.S Sale | −$46.2K |
| 2025-09-12 | PRGOPERRIGO Co plc · Restricted Stock UnitsA Award | — |
| 2025-08-18 | PRGOPERRIGO Co plcP Purchase | +$100K |
| 2025-08-18 | PRGOPERRIGO Co plcP Purchase | +$100K |
| 2025-06-13 | PRGOPERRIGO Co plc · Restricted Stock UnitsA Award | — |
| 2025-05-14 | PRGOPERRIGO Co plcM Exercise/Conversion | +$258K |
| 2025-05-14 | PRGOPERRIGO Co plcF Tax Payment | −$124K |
| 2025-05-14 | PRGOPERRIGO Co plc · Restricted Stock UnitsA Award | — |
| 2025-05-14 | PRGOPERRIGO Co plc · Restricted Stock UnitsM Exercise/Conversion | — |
| 2025-05-12 | PRGOPERRIGO Co plcP Purchase | +$94.9K |
| 2025-02-03 | ALLOAllogene Therapeutics, Inc.S Sale | −$7,544.53 |
| 2025-01-24 | ALLOAllogene Therapeutics, Inc.A Award | — |
| 2025-01-24 | ALLOAllogene Therapeutics, Inc. · Stock Option (Right to buy)A Award | — |
| 2024-10-21 | ALLOAllogene Therapeutics, Inc.F Tax Payment | −$103K |
| 2024-05-16 | ALLOAllogene Therapeutics, Inc.A Award | +$1M |
| 2024-05-15 | PRGOPERRIGO Co plcF Tax Payment | −$127K |
| 2024-05-15 | PRGOPERRIGO Co plc · Restricted Stock UnitsM Exercise/Conversion | — |
| 2024-05-15 | PRGOPERRIGO Co plcM Exercise/Conversion | +$265K |
| 2024-05-14 | PRGOPERRIGO Co plc · Restricted Stock UnitsA Award | — |
| 2024-01-30 | ALLOAllogene Therapeutics, Inc.P Purchase | +$683.05 |
| 2024-01-25 | ALLOAllogene Therapeutics, Inc.A Award | — |
| 2024-01-25 | ALLOAllogene Therapeutics, Inc. · Stock Option (Right to buy)A Award | — |
| 2023-12-18 | Better Therapeutics, Inc.A Award | — |
| 2023-10-16 | ALLOAllogene Therapeutics, Inc.A Award | — |
| 2023-10-16 | ALLOAllogene Therapeutics, Inc.A Award | — |
| 2023-10-16 | ALLOAllogene Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2023-07-27 | Better Therapeutics, Inc.P Purchase | +$500K |
| 2023-06-13 | PRGOPERRIGO Co plcP Purchase | +$331K |
| 2023-06-07 | Better Therapeutics, Inc.Stock Option (Right to Buy)A Award | — |
| 2023-05-17 | PRGOPERRIGO Co plcM Exercise/Conversion | +$256K |
| 2023-05-17 | PRGOPERRIGO Co plcF Tax Payment | −$123K |
| 2023-05-17 | PRGOPERRIGO Co plc · Restricted Stock UnitsM Exercise/Conversion | — |
| 2023-05-15 | PRGOPERRIGO Co plc · Restricted Stock UnitsA Award | — |
| 2023-04-10 | Better Therapeutics, Inc.P Purchase | +$250K |
| 2023-03-06 | PRGOPERRIGO Co plcP Purchase | +$190K |
| 2022-10-20 | ChemoCentryx, Inc.D Disposition to Issuer | — |
| 2022-10-20 | ChemoCentryx, Inc.D Disposition to Issuer | — |
Recent filings
- 4Parker Geoffrey M.0001585364-26-000151SEC(opens sec.gov)
- 4Parker Geoffrey M.0001585364-26-000097SEC(opens sec.gov)
- 4Parker Geoffrey M.0001491874-26-000002SEC(opens sec.gov)
- 4Parker Geoffrey M.0001737287-26-000007SEC(opens sec.gov)
- 4Parker Geoffrey M.0001491874-25-000009SEC(opens sec.gov)
- 4Parker Geoffrey M.0001491874-25-000007SEC(opens sec.gov)
- 4Parker Geoffrey M.0001737287-25-000091SEC(opens sec.gov)
- 4Parker Geoffrey M.0001585364-25-000146SEC(opens sec.gov)
- 4/AParker Geoffrey M.0001585364-25-000130SEC(opens sec.gov)
- 4Parker Geoffrey M.0001585364-25-000128SEC(opens sec.gov)
- 4Parker Geoffrey M.0001585364-25-000107SEC(opens sec.gov)
- 4Parker Geoffrey M.0001585364-25-000074SEC(opens sec.gov)
Companies
- Allogene Therapeutics, Inc.CHIEF FINANCIAL OFFICERALLO
- Anacor Pharmaceuticals, Inc.Executive Vice President & CFO
- Better Therapeutics, Inc.Director
- ChemoCentryx, Inc.Director
- GENOMIC HEALTH INCDirector
- GENOPTIX INCDirector
- PERRIGO Co plcDirectorPRGO
- Tricida, Inc.COO, CFO and EVP
- Viracta Therapeutics, Inc.DirectorVIRX
Address
C/O PERRIGO COMPANY PLC 515 EASTERN AVENUE
ALLEGAN, MI, 49010